Which drug prices should medicare negotiate? A "Too Little" or "Too Late" approach Editorial
| Author: | Bach, P. B. |
| Title: | Which drug prices should medicare negotiate? A "Too Little" or "Too Late" approach |
| Keywords: | review; drug approval; united states; food and drug administration; cost control; cost effectiveness analysis; drug cost; medicare; prescription; economics; drug costs; interpersonal communication; cost benefit analysis; government regulation; drug industry; economic evaluation; negotiating; drug legislation; priority journal; legislation and jurisprudence; cost minimization analysis |
| Journal Title: | New England Journal of Medicine |
| Volume: | 381 |
| Issue: | 22 |
| ISSN: | 0028-4793 |
| Publisher: | Massachusetts Medical Society |
| Date Published: | 2019-11-29 |
| Start Page: | 2084 |
| End Page: | 2086 |
| Language: | English |
| DOI: | 10.1056/NEJMp1912736 |
| PUBMED: | 31774952 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Review -- Source: Scopus |
